Search
for
Sort by
Research 271–300 of 1000+
- Clinical and dermoscopic features of lichen planus pigmentosus in 37 patients with frontal fibrosing alopecia
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism.
- Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures
- Albendazole treatment of echinococcosis in humans: Effects on microsomal metabolism and drug tolerance
- Role of platelet-rich plasma in chronic alopecia areata: Our centre experience
- Implication of allopregnanolone in the antinociceptive effect of N -palmitoylethanolamide in acute or persistent pain
- Alopecia areata as another immune‐mediated disease developed in patients treated with tumour necrosis factor‐α blocker agents
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Studies on Neurosteroids XXV. Influence of a 5.ALPHA.-Reductase Inhibitor, Finasteride, on Rat Brain Neurosteroid Levels and Metabolism
- Combination of topical garlic gel and betamethasone valerate cream in the treatment of localized alopecia areata: A double-blind randomized controlled study
- Dietary soy oil content and soy‐derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice
- Traction alopecia: the root of the problem
- The role of lymphocytes in the development and treatment of alopecia areata
- Alopecia areata incognita: A Hypothesis
- Treatment of severe alopecia areata with intralesional steroid injections.
- Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata
- Multi-layered environmental regulation on the homeostasis of stem cells: The saga of hair growth and alopecia
- Acute Diffuse and Total Alopecia of the Female Scalp
- The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results
- Review of quality of life studies in women with alopecia
- Platelet-rich plasma as a potential treatment for noncicatricial alopecias
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- Alopecia Areata: Current Treatments and New Directions
- Immunological Properties of Atopic Dermatitis-Associated Alopecia Areata
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Treatment of male pattern alopecia with platelet-rich plasma: A double-blind controlled study with analysis of platelet number and growth factor levels